2012, ISBN: 9781627030076
Methods and Protocols, Buch, Hardcover, 2012 ed. Over the past three decades there have been new developments in therapeutic drug design. In Rational Drug Design: Methods and Protocols, … Mehr…
lehmanns.de Versandkosten:Versand in 10-14 Tagen. (EUR 0.00) Details... |
ISBN: 9781627030076
Over the past three decades there have been new developments in therapeutic drug design. In Rational Drug Design: Methods and Protocols, expert researchers in the field detail many of t… Mehr…
Springer.com Nr. 978-1-62703-007-6. Versandkosten:Worldwide free shipping, , DE. (EUR 0.00) Details... |
2012, ISBN: 1627030077
2012 Gebundene Ausgabe Chemie / Medizin, Arznei / Arzneimittellehre, Pharmakologie, Toxikologie, Medizinische Chemie, Pharmazeutische Chemie, ATPbinding; GTPases; Structurebasedvirtuals… Mehr…
Achtung-Buecher.de MARZIES.de Buch- und Medienhandel, 14621 Schönwalde-Glien Versandkosten:Versandkostenfrei innerhalb der BRD. (EUR 0.00) Details... |
2012, ISBN: 1627030077
This Methods in Molecular Biology(TM) book details rational drug design, including virtual screening of chemical hits, lead discovery by high throughput screening, combinatorial and fragm… Mehr…
Weltbild.de Nr. 38367744. Versandkosten:, 2-5 Werktage, DE. (EUR 0.00) Details... |
2012, ISBN: 1627030077
[EAN: 9781627030076], Neubuch, [PU: Humana Press], pp. 244, Books
AbeBooks.de Books Puddle, New York, NY, U.S.A. [70780988] [Rating: 4 (von 5)] NEW BOOK. Versandkosten: EUR 8.17 Details... |
2012, ISBN: 9781627030076
Methods and Protocols, Buch, Hardcover, 2012 ed. Over the past three decades there have been new developments in therapeutic drug design. In Rational Drug Design: Methods and Protocols, … Mehr…
ISBN: 9781627030076
Over the past three decades there have been new developments in therapeutic drug design. In Rational Drug Design: Methods and Protocols, expert researchers in the field detail many of t… Mehr…
2012
ISBN: 1627030077
2012 Gebundene Ausgabe Chemie / Medizin, Arznei / Arzneimittellehre, Pharmakologie, Toxikologie, Medizinische Chemie, Pharmazeutische Chemie, ATPbinding; GTPases; Structurebasedvirtuals… Mehr…
2012, ISBN: 1627030077
This Methods in Molecular Biology(TM) book details rational drug design, including virtual screening of chemical hits, lead discovery by high throughput screening, combinatorial and fragm… Mehr…
2012, ISBN: 1627030077
[EAN: 9781627030076], Neubuch, [PU: Humana Press], pp. 244, Books
Bibliographische Daten des bestpassenden Buches
Autor: | |
Titel: | |
ISBN-Nummer: |
Detailangaben zum Buch - Rational Drug Design
EAN (ISBN-13): 9781627030076
ISBN (ISBN-10): 1627030077
Gebundene Ausgabe
Erscheinungsjahr: 2012
Herausgeber: Humana Press Inc.
230 Seiten
Gewicht: 0,629 kg
Sprache: Englisch
Buch in der Datenbank seit 2009-10-17T17:11:46+02:00 (Berlin)
Detailseite zuletzt geändert am 2024-03-03T18:36:28+01:00 (Berlin)
ISBN/EAN: 1627030077
ISBN - alternative Schreibweisen:
1-62703-007-7, 978-1-62703-007-6
Alternative Schreibweisen und verwandte Suchbegriffe:
Autor des Buches: zheng
Titel des Buches: design methods, rational design, zheng
Daten vom Verlag:
Autor/in: Yi Zheng
Titel: Methods in Molecular Biology; Rational Drug Design - Methods and Protocols
Verlag: Humana; Humana Press
230 Seiten
Erscheinungsjahr: 2012-09-06
Totowa; NJ; US
Gedruckt / Hergestellt in Niederlande.
Gewicht: 0,663 kg
Sprache: Englisch
106,99 € (DE)
109,99 € (AT)
118,00 CHF (CH)
POD
XI, 230 p. 58 illus., 22 illus. in color.
BB; Pharmacology/Toxicology; Hardcover, Softcover / Medizin/Pharmazie; Pharmakologie; Verstehen; ATP binding; GTPases; Structure based virtual screening; anti-sense microRNA; drug discovery; drug resistance; molecular biology; phosphotases; rational designed; wnt pathway targets; Medicinal Chemistry; Pharmacology; Medicinal Chemistry; Medizinische Chemie, Pharmazeutische Chemie; EA; BC
1. On Setting up and Assessing Docking Simulations for Virtual ScreeningJacek Biesiada, Aleksey Porollo, Jaroslaw Meller 2. Virtual Ligand Screening Combined with NMR to Identify Dvl PDZ Domain Inhibitors Targeting the Wnt SignalingJufang Shan and Jie J. Zheng 3. Rational Design of Rho GTPase Targeting InhibitorsXun Shang and Yi Zheng 4. Rational Design of Peptide Ligands Against a Glycolipid by NMR StudiesWenyong Tong, Tara Sprules, Kalle Gehring, H. Uri Saragovi 5. A Combinatorial Strategy for the Acquisition of Potent and Specific Protein Tyrosine Phosphatase InhibitorsSheng Zhang, Lan Chen, David S. Lawrence and Zhong-Yin Zhang 6. Identification of Allosteric Inhibitors of p21-Activated KinaseJulien Viaud and Jeffrey R. Peterson 7. Using a Modified Yeast Two-hybrid System to Screen for Chemical GEF InhibitorsAnne Blangy and Philippe Fort . 8. Random Mutagenesis of Peptide Aptamers As An Optimization Strategy for Inhibitor ScreeningNathalie Bouquier, Sylvie Fromont, Anne Debant and Susanne Schmidt 9. A Screening Strategy for Trapping the Inactive Conformer of a Dimeric Enzyme with a Small Molecule InhibitorTina Shahian and Charles S. Craik 10. Use of a Fluorescent ATP Analog to Probe the Allosteric Conformational Change in the Active Site of the Protein Kinase PDK1Valerie Hindie, Laura A. Lopez-Garcia, and Ricardo M. Biondi 11. Affinity Purification of Protein Kinases that Adopt a Specific Inactive ConformationPratistha Ranjitkar and Dustin J. Maly 12. Determination of the Kinetics and Thermodynamics of Ligand Binding to a Specific Inactive Conformation in Protein KinasesSanjay B. Hari, Pratistha Ranjitkar and Dustin J. Maly 13. Purification and Specific Assays for Measuring APE-1 Endonuclease ActivityAdrian Esqueda, Mohammed Z Mohammed, Srinivasan Madhusudan, and Nouri Neamati 14. An in vitro Screening to Identify Drug Resistant Mutations for Target-directed Chemotherapeutic AgentsMohammad Azam 15. Utilizing AntagomiR (anti-sense microRNA) to Knock Down microRNA in Murine Bone Marrow CellsChinavenmeni S. Velu and H. Leighton Grimes 16. Synthesis, Conjugation, and Labeling of Multifunctional pRNA Nanoparticles for Specific Delivery of siRNA, Drugs and Other Therapeutics to Target CellsMathieu Cinier, Yi Shu, Daniel Binzel, and Peixuan Guo 17. Mouse Models for Tumor MetastasisShengyu Yang, J. Jillian Zhang, and Xin-Yun Huang1. On Setting up and Assessing Docking simulations for Virtual ScreeningJacek Biesiada, Aleksey Porollo, Jaroslaw Meller 2. Virtual Ligand Screening Combined with NMR to Identify Dvl PDZ Domain Inhibitors Targeting the Wnt SignalingJufang Shan and Jie J. Zheng 3. Rational Design of Rho GTPase Targeting InhibitorsXun Shang and Yi Zheng 4. Rational Design of Peptide Ligands Against a Glycolipid by NMR StudiesWenyong Tong, Tara Sprules, Kalle Gehring, H. Uri Saragovi 5. A Combinatorial Strategy for the Acquisition of Potent and Specific Protein Tyrosine Phosphatase InhibitorsSheng Zhang, Lan Chen, David S. Lawrence and Zhong-Yin Zhang 6. Identification of Allosteric Inhibitors of p21-Activated KinaseJulien Viaud and Jeffrey R. Peterson 7. Using a Modified Yeast Two-hybrid System to Screen for Chemical GEF InhibitorsAnne Blangy and Philippe Fort . 8. Random Mutagenesis of Peptide Aptamers As An Optimization Strategy for Inhibitor ScreeningNathalie Bouquier, Sylvie Fromont, Anne Debant and Susanne Schmidt 9. A Screening Strategy for Trapping the Inactive Conformer of a Dimeric Enzyme with a Small Molecule InhibitorTina Shahian and Charles S. Craik 10. Use of a Fluorescent ATP Analog to Probe the Allosteric Conformational Change in the Active Site of the Protein Kinase PDK1Valerie Hindie, Laura A. Lopez-Garcia, and Ricardo M. Biondi 11. Affinity Purification of Protein Kinases that Adopt a Specific Inactive ConformationPratistha Ranjitkar and Dustin J. Maly 12. Determination of the Kinetics and Thermodynamics of Ligand Binding to a Specific Inactive Conformation in Protein KinasesSanjay B. Hari, Pratistha Ranjitkar and Dustin J. Maly 13. Purification and Specific Assays for Measuring APE-1 Endonuclease ActivityAdrian Esqueda, Mohammed Z Mohammed, Srinivasan Madhusudan, and Nouri Neamati 14. An in vitro Screening to Identify Drug Resistant Mutations for Target-directed Chemotherapeutic AgentsMohammad Azam 15. Utilizing AntagomiR (anti-sense microRNA) to Knock Down microRNA in Murine Bone Marrow CellsChinavenmeni S. Velu and H. Leighton Grimes 16. Synthesis, Conjugation, and Labeling of Multifunctional pRNA Nanoparticles for Specific Delivery of siRNA, Drugs and Other Therapeutics to Target CellsMathieu Cinier, Yi Shu, Daniel Binzel, and Peixuan Guo 17. Mouse Models for Tumor MetastasisShengyu Yang, J. Jillian Zhang, and Xin-Yun Huang1. On Setting up and Assessing Docking simulations for Virtual ScreeningJacek Biesiada, Aleksey Porollo, Jaroslaw Meller 2. Virtual Ligand Screening Combined with NMR to Identify Dvl PDZ Domain Inhibitors Targeting the Wnt SignalingJufang Shan and Jie J. Zheng 3. Rational Design of Rho GTPase Targeting InhibitorsXun Shang and Yi Zheng 4. Rational Design of Peptide Ligands Against a Glycolipid by NMR StudiesWenyong Tong, Tara Sprules, Kalle Gehring, H. Uri Saragovi 5. A Combinatorial Strategy for the Acquisition of Potent and Specific Protein Tyrosine Phosphatase InhibitorsSheng Zhang, Lan Chen, David S. Lawrence and Zhong-Yin Zhang 6. Identification of Allosteric Inhibitors of p21-Activated KinaseJulien Viaud and Jeffrey R. Peterson 7. Using a Modified Yeast Two-hybrid System to Screen for Chemical GEF InhibitorsAnne Blangy and Philippe Fort . 8. Random Mutagenesis of Peptide Aptamers As An Optimization Strategy for Inhibitor ScreeningNathalie Bouquier, Sylvie Fromont, Anne Debant and Susanne Schmidt 9. A Screening Strategy for Trapping the Inactive Conformer of a Dimeric Enzyme with a Small Molecule InhibitorTina Shahian and Charles S. Craik 10. Use of a Fluorescent ATP Analog to Probe the Allosteric Conformational Change in the Active Site of the Protein Kinase PDK1Valerie Hindie, Laura A. Lopez-Garcia, and Ricardo M. Biondi 11. Affinity Purification of Protein Kinases that Adopt a Specific Inactive ConformationPratistha Ranjitkar and Dustin J. Maly 12. Determination of the Kinetics and Thermodynamics of Ligand Binding to a Specific Inactive Conformation in Protein KinasesSanjay B. Hari, Pratistha Ranjitkar and Dustin J. Maly 13. Purification and Specific Assays for Measuring APE-1 Endonuclease ActivityAdrian Esqueda, Mohammed Z Mohammed, Srinivasan Madhusudan, and Nouri Neamati 14. An in vitro Screening to Identify Drug Resistant Mutations for Target-directed Chemotherapeutic AgentsMohammad Azam 15. Utilizing AntagomiR (anti-sense microRNA) to Knock Down microRNA in Murine Bone Marrow CellsChinavenmeni S. Velu and H. Leighton Grimes 16. Synthesis, Conjugation, and Labeling of Multifunctional pRNA Nanoparticles for Specific Delivery of siRNA, Drugs and Other Therapeutics to Target CellsMathieu Cinier, Yi Shu, Daniel Binzel, and Peixuan Guo 17. Mouse Models for Tumor MetastasisShengyu Yang, J. Jillian Zhang, and Xin-Yun HuangWeitere, andere Bücher, die diesem Buch sehr ähnlich sein könnten:
Neuestes ähnliches Buch:
9781493993475 Rational Drug Design (Herausgegeben:Mavromoustakos, Thomas; Kellici, Tahsin F.)
- 9781493993475 Rational Drug Design (Herausgegeben:Mavromoustakos, Thomas; Kellici, Tahsin F.)
- 9781493959006 Rational Drug Design: Methods And Protocols (Humana Press)
- 9781493986293 Rational Drug Design (Herausgegeben:Kellici, Tahsin F.; Mavromoustakos, Thomas)
- Rational Drug Design. Methods and Protocols. (Mavromoustakos, T. et al (Eds.))
< zum Archiv...